Androstane-3β-O-sulfonate 및 -sulfamate 유도체 합성과 steroid sulfatase 저해효과 = Synthesis and Steroid Sulfatase Inhibitory Effect of Androstane-3β-O-sulfonate and -sulfamate Derivatives

국문 초록 (Abstract)

서 론(Introduction) 실험 방법(Experimental Methods) 결과 및 고찰(Results and Discussion) 결 론(Conclusion)

목차 (Table of Contents)

• The development of potent steroid sulfatase inhibitors is an important new therapeutic strategy for the treatment of postmenopausal women with breast cancer. In postmenopausal breast cancer, the desulfation of dehydroepiandrostene sulfate (DHEAS) by steroid sulfatase (STS) that takes place in peripheral tissues becomes as an important step in estrogen production. Androstane-3β-O-mesylsulfonate, -3β-O-tosylsulfonate, and -3β-O-sulfamate derivatives with substituents at positions 5 and 6 were synthesized using DHEA as the parent structure and STS inhibitory activity was measured at 3 μM in human Jeg-3 cells. 6β-Chloro-5α-hydroxyandrostane-3β-O-sulfamate (13) was found to be the most active compound with STS inhibition 71%.

참고문헌 (Reference)

1 Ciobanu L.C, "Synthesis and steroid sulphatase inhibitory activity of C19- and C21-steroidal derivatives bearing a benzyl-inhibiting group" 36 : 659-, 2001

2 Lo Y.S, "Synthesis and physicochemical properties of sulfamate derivatives as topical antiglucoma agent" 35 : 4790-, 1992

3 Woo L.W.L, "Steroidal and non-steroidal sulfamates as potent inhibitors of steroid sulfatase" 41 : 1068-, 1998

4 Reed M.J, "Steroid sulfatase: molecular biology, regulation, and inhibition" 26 : 171-, 2005

5 Nakata T, "Role of steroid sulfatase in local formationof estrogen in menopausal breast cancer patients" 86 : 455-, 2003

6 Pasqualini J.R, "Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cance." 93 : 221-, 2005

7 Pasqualini J.R., "Metabolism and biologic response of estrogen sulfates in hormone-dependent and hormone-independent mammary cancer cell lines" 464 : 106-, 1986

8 Labrie F., "Intracrinology" 78 : C113-, 1991

9 Ishida H, "Inhibition of steroid sulfatase activity and cell proliferation in ZR-75-1 and BT-474 human breast cancer cells by KW-2581 in vitro and in vivo" 104 : 211-, 2007

10 Numazawa M, "Inhibition of estrone sulfatase by aromatase inhibitor-based estrone 3sulfamates" 71 : 371-, 2006

11 Ishida H, "Inactivation of recombinant human steroid sulfatase by KW2581" 128 : 17-, 2008

12 Foster P.A, "In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer" 12 : 5543-, 2006

13 Purohit A, "In vivo activity of 4-methylcoumarin-7-Osulfamate, a non-steroidal, steroidal sulphatase inhibitor" 159 : 4950-, 1996

14 Santner S.J, "In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway" 59 : 29-, 1984

15 Harworth M.V, "Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential" 37 : 219-, 1994

16 Schreiner E.P, "Estrone formate: a novel type of irreversible inhibitor of human steoid sulfatase" 14 : 4999-, 2004

17 Kim E., "Epoxidation and reduction of DHEA, 1,4,6androstatriene-3-one and 4,6-androstadien-3β,17β-diol" 10 : 572-, 2005

18 van Landeghem A.A.J, "Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue" 45 : 2900-, 1985

19 Woo L.W.L, "Development of steroid sulfatase inhibitors" 340 : 175-, 2011

20 El-Gamal M.I, "Design, synthesis, and biological evaluation of new arylamide derivatives possessing sulfonates or sulfamate moieties as steroid sulfatase enzyme" 24 : 2762-, 2016

21 Pasqualini J.R, "Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients" 81 : 1460-, 1996

22 Pasqualini J.R, "Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients" 81 : 1460-, 1996

23 Chetrite G.S, "Comparison of estrogen concentrations, estrogen sulfatase and aromatase activities in normal, and in cancerous, human breast tissues" 72 : 23-, 2000

24 Hanson J.R, "Androsta-2,4-diene-6,17-dione" 18 : 2473-, 1970

25 Ciobanu L.C, "3 Sulfamate derivatives of C19 and C21 steroids bearing a tbutylbenzyl or benzyl group: synthesis and evaluation as nonestrogenic and non-androgenic steroid sulfatase inhibitors" 18 : 15-, 2003